Theragnostic Technologies Receives Small Business Technology Transfer (STTR) Phase I Award in Partne

Theragnostic Technologies has received Phase I Small Business Technology Transfer (STTR) grant from the National Institute of Diabestes and Digestive and Kidney Diseases in collaboration with Stony Brook University. This STTR phase 1 proposal investigates the safety and efficacy of a novel high-performance carbon nanostructure-based magnetic resonance imaging (MRI) contrast agent for the imaging and monitoring of patients with renal failure.

The research will be led by Dr. Balaji Sitharaman in the Department of Biomedical Engineering. Dr Kenneth Shroyer (Department of Pathology) and Dr. William Moore (Department of Radiology) serve as clinical co-PIs in partnership with Scientists at Theragnostic Technologies.